These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
385 related articles for article (PubMed ID: 8521414)
1. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Shapiro GI; Park JE; Edwards CD; Mao L; Merlo A; Sidransky D; Ewen ME; Rollins BJ Cancer Res; 1995 Dec; 55(24):6200-9. PubMed ID: 8521414 [TBL] [Abstract][Full Text] [Related]
2. P16Ink4a tumor suppressor function in lung cancer cells involves cyclin-dependent kinase 2 inhibition by Cip/Kip protein redistribution. Grimison B; Langan TA; Sclafani RA Cell Growth Differ; 2000 Oct; 11(10):507-15. PubMed ID: 11063124 [TBL] [Abstract][Full Text] [Related]
3. Mechanisms of p16INK4A inactivation in non small-cell lung cancers. Gazzeri S; Gouyer V; Vour'ch C; Brambilla C; Brambilla E Oncogene; 1998 Jan; 16(4):497-504. PubMed ID: 9484839 [TBL] [Abstract][Full Text] [Related]
4. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Easton J; Wei T; Lahti JM; Kidd VJ Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589 [TBL] [Abstract][Full Text] [Related]
5. Expression of p16INK4a/p16alpha and p19ARF/p16beta is frequently altered in non-small cell lung cancer and correlates with p53 overexpression. Vonlanthen S; Heighway J; Tschan MP; Borner MM; Altermatt HJ; Kappeler A; Tobler A; Fey MF; Thatcher N; Yarbrough WG; Betticher DC Oncogene; 1998 Nov; 17(21):2779-85. PubMed ID: 9840942 [TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas. Elisei R; Shiohara M; Koeffler HP; Fagin JA Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724 [TBL] [Abstract][Full Text] [Related]
8. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK; Medina D Mol Carcinog; 1998 Jun; 22(2):128-43. PubMed ID: 9655257 [TBL] [Abstract][Full Text] [Related]
9. Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Shapiro GI; Edwards CD; Kobzik L; Godleski J; Richards W; Sugarbaker DJ; Rollins BJ Cancer Res; 1995 Feb; 55(3):505-9. PubMed ID: 7834618 [TBL] [Abstract][Full Text] [Related]
10. Analysis of the Rb gene and cyclin-dependent kinase 4 inhibitor genes (p16INK4 and p15INK4B) in human ovarian carcinoma cell lines. Yaginuma Y; Hayashi H; Kawai K; Kurakane T; Saitoh Y; Kitamura S; Sengoku K; Ishikawa M Exp Cell Res; 1997 Jun; 233(2):233-9. PubMed ID: 9194486 [TBL] [Abstract][Full Text] [Related]
11. Re-expression of endogenous p16ink4a in oral squamous cell carcinoma lines by 5-aza-2'-deoxycytidine treatment induces a senescence-like state. Timmermann S; Hinds PW; Münger K Oncogene; 1998 Dec; 17(26):3445-53. PubMed ID: 10030668 [TBL] [Abstract][Full Text] [Related]
12. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines. Fujishita T; Mizushima Y; Kashii T; Kobayashi M Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367 [TBL] [Abstract][Full Text] [Related]
13. Elevated activity of cyclin-dependent kinase 6 in human squamous cell carcinoma lines. Timmermann S; Hinds PW; Münger K Cell Growth Differ; 1997 Apr; 8(4):361-70. PubMed ID: 9101082 [TBL] [Abstract][Full Text] [Related]
14. Aberrant p16 expression is correlated with hemizygous deletions at the 9p21-22 chromosome region in non-small cell lung carcinomas. Spanakis NE; Gorgoulis V; Mariatos G; Zacharatos P; Kotsinas A; Garinis G; Trigidou R; Karameris A; Tsimara-Papastamatiou H; Kouloukousa M; Manolis EN; Kittas C Anticancer Res; 1999; 19(3A):1893-9. PubMed ID: 10470133 [TBL] [Abstract][Full Text] [Related]
15. Absence of p16INK4 protein is restricted to the subset of lung cancer lines that retains wildtype RB. Otterson GA; Kratzke RA; Coxon A; Kim YW; Kaye FJ Oncogene; 1994 Nov; 9(11):3375-8. PubMed ID: 7936665 [TBL] [Abstract][Full Text] [Related]
16. Homozygous codeletion and differential decreased expression of p15INK4b, p16INK4a-alpha and p16INK4a-beta in mouse lung tumor cells. Herzog CR; Soloff EV; McDoniels AL; Tyson FL; Malkinson AM; Haugen-Strano A; Wiseman RW; Anderson MW; You M Oncogene; 1996 Nov; 13(9):1885-91. PubMed ID: 8934534 [TBL] [Abstract][Full Text] [Related]
17. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage. Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613 [TBL] [Abstract][Full Text] [Related]
18. Growth inhibition and induction of apoptosis by flavopiridol in rat lung adenocarcinoma, osteosarcoma and malignant fibrous histiocytoma cell lines. Honoki K; Yoshitani K; Tsujiuchi T; Mori T; Tsutsumi M; Morishita T; Takakura Y; Mii Y Oncol Rep; 2004 May; 11(5):1025-30. PubMed ID: 15069542 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein. Yu B; Lane ME; Pestell RG; Albanese C; Wadler S Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Geradts J; Kratzke RA; Niehans GA; Lincoln CE Cancer Res; 1995 Dec; 55(24):6006-11. PubMed ID: 8521382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]